These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

929 related items for PubMed ID: 19632742

  • 1. Intravascular large B-cell lymphoma: remission after rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisolone chemotherapy.
    Horváth B, Demeter J, Eros N, Hársing J, Csomor J, Matolcsy A, Bottlik G, Gyori G, Marschalkó M, Kárpáti S.
    J Am Acad Dermatol; 2009 Nov; 61(5):885-8. PubMed ID: 19632742
    [Abstract] [Full Text] [Related]

  • 2. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
    Feldmann R, Schierl M, Sittenthaler M, Jahn R, Wogritsch C, Cerroni L, Steiner A, Breier F.
    Dermatology; 2009 Nov; 219(4):344-6. PubMed ID: 19590171
    [Abstract] [Full Text] [Related]

  • 3. [A case of pulmonary intravascular lymphoma treated with CHOP chemotherapy plus rituximab].
    Ohkubo H, Yoshida T, Ohta K, Takaku T, Katagiri T, Paku J, Kasuga I, Minemura K, Gotoh A, Serizawa H, Mukai K, Ohyashiki K.
    Gan To Kagaku Ryoho; 2005 Apr; 32(4):553-6. PubMed ID: 15853227
    [Abstract] [Full Text] [Related]

  • 4. Malignant lymphomas in the elderly.
    O'Reilly SE, Connors JM, Macpherson N, Klasa R, Hoskins P.
    Clin Geriatr Med; 1997 May; 13(2):251-63. PubMed ID: 9115450
    [Abstract] [Full Text] [Related]

  • 5. Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract.
    Tamura S, Ohkawauchi K, Yokoyama Y, Higashidani Y, Daibata M, Hiroi M, Yamamori S, Onishi S.
    J Gastroenterol; 2004 Oct; 39(10):995-1000. PubMed ID: 15549454
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of diffuse large B-cell lymphoma].
    Gleissner B, Zwick C, Pfreundschuh M.
    Dtsch Med Wochenschr; 2008 Sep; 133(36):1785-94; quiz 1795-6. PubMed ID: 18767006
    [Abstract] [Full Text] [Related]

  • 7. Intravascular B-cell lymphoma: the role of skin biopsy.
    Barnett CR, Seo S, Husain S, Grossman ME.
    Am J Dermatopathol; 2008 Jun; 30(3):295-9. PubMed ID: 18496438
    [Abstract] [Full Text] [Related]

  • 8. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R, Hagenbeek A.
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [Abstract] [Full Text] [Related]

  • 9. Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
    Go A, Venugopal P, Loew J, Djordjevic D.
    Clin Adv Hematol Oncol; 2006 Jun; 4(6):439-41. PubMed ID: 16981666
    [No Abstract] [Full Text] [Related]

  • 10. Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
    Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.
    J Clin Oncol; 2009 Feb 01; 27(4):605-11. PubMed ID: 19075267
    [Abstract] [Full Text] [Related]

  • 11. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
    Posada García C, Florez A, Pardavila R, Garcia-Cruz A, Amador L, Alvarez M, Alberte LM, Cruces MJ.
    Eur J Dermatol; 2009 Feb 01; 19(4):394-5. PubMed ID: 19467966
    [No Abstract] [Full Text] [Related]

  • 12. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in 'Western' patients with intravascular large B-cell lymphoma.
    Ferreri AJ, Dognini GP, Bairey O, Szomor A, Montalbán C, Horvath B, Demeter J, Uziel L, Soffietti R, Seymour JF, Ambrosetti A, Willemze R, Martelli M, Rossi G, Candoni A, De Renzo A, Doglioni C, Zucca E, Cavalli F, Ponzoni M, International Extranodal Lymphoma Study Group.
    Br J Haematol; 2008 Oct 01; 143(2):253-7. PubMed ID: 18699850
    [Abstract] [Full Text] [Related]

  • 13. Prostate involvement by intravascular large B-cell lymphoma: a case report with literature review.
    Xu M, Yang Q, Li M, Geng W, Huang W, Chen Y.
    Int J Surg Pathol; 2011 Aug 01; 19(4):544-7. PubMed ID: 21632638
    [Abstract] [Full Text] [Related]

  • 14. Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
    Al-Katib AM, Aboukameel A, Mohammad R, Bissery MC, Zuany-Amorim C.
    Clin Cancer Res; 2009 Jun 15; 15(12):4038-45. PubMed ID: 19509168
    [Abstract] [Full Text] [Related]

  • 15. [Dramatic but temporary improvements in a case of CNS intravascular malignant lymphomatosis].
    Aoyama M, Aoki T, Matsuura Y, Yamanoi T, Watanabe A, Saitou N, Honma M, Ishikawa T, Kodama N, Yamamoto T.
    Rinsho Shinkeigaku; 2003 Jun 15; 43(1-2):6-11. PubMed ID: 12820543
    [Abstract] [Full Text] [Related]

  • 16. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T, Nochy D, Montravers F, Der Sahakian G, Fior R, Galanaud P, Boué F.
    Leuk Lymphoma; 2004 Aug 15; 45(8):1703-5. PubMed ID: 15370230
    [Abstract] [Full Text] [Related]

  • 17. Rituximab and its role as maintenance therapy in non-Hodgkin lymphoma.
    Collins-Burow B, Santos ES.
    Expert Rev Anticancer Ther; 2007 Mar 15; 7(3):257-73. PubMed ID: 17338647
    [Abstract] [Full Text] [Related]

  • 18. Impressive response to temsirolimus in a patient with chemotherapy refractory diffuse large B-cell non-Hodgkin's lymphoma.
    Kiewe P, Thiel E.
    Ann Hematol; 2011 Jan 15; 90(1):109-10. PubMed ID: 20387065
    [No Abstract] [Full Text] [Related]

  • 19. Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma.
    Hosoi M, Yamamoto G, Imai Y, Kurokawa M.
    Ann Hematol; 2010 Feb 15; 89(2):207-8. PubMed ID: 19582454
    [No Abstract] [Full Text] [Related]

  • 20. Disseminated intravascular B-cell lymphoma: clinicopathological features and outcome of three cases treated with anthracycline-based immunochemotherapy.
    Bouzani M, Karmiris T, Rontogianni D, Delimpassi S, Apostolidis J, Mpakiri M, Nikiforakis E.
    Oncologist; 2006 Sep 15; 11(8):923-8. PubMed ID: 16951396
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.